XQRONA Trademark

Trademark Overview

On Monday, June 29, 2020, a trademark application was filed for XQRONA with the United States Patent and Trademark Office. The USPTO has given the XQRONA trademark a serial number of 90026286. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The XQRONA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
xqrona

General Information

Serial Number90026286
Word MarkXQRONA
Filing DateMonday, June 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023SOU EXTENSION 5 GRANTED
Tuesday, April 4, 2023SOU EXTENSION 5 FILED
Wednesday, April 12, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 4, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 10, 2022SOU EXTENSION 4 GRANTED
Monday, October 10, 2022SOU EXTENSION 4 FILED
Monday, October 10, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 27, 2022SOU EXTENSION 3 FILED
Wednesday, April 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Saturday, October 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 14, 2021SOU EXTENSION 2 GRANTED
Thursday, October 14, 2021SOU EXTENSION 2 FILED
Thursday, October 14, 2021SOU TEAS EXTENSION RECEIVED
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, April 14, 2021SOU EXTENSION 1 FILED
Wednesday, April 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 31, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, July 24, 2020ASSIGNED TO EXAMINER
Friday, July 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 23, 2020PETITION TO DIRECTOR GRANTED
Tuesday, July 21, 2020ASSIGNED TO PETITION STAFF
Monday, July 13, 2020TEAS PETITION TO DIRECTOR RECEIVED
Thursday, July 9, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, July 9, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, July 2, 2020NEW APPLICATION ENTERED

Related Keywords

xqrona respiratory diseases disorders disease coronavirus treatment prevention covid antivirals preparations